Lauxera Capital Partners
Independent international investment firm providing growth equity to revenue-generating, breakeven or early-profit Healthtech companies, with support for scaling and US and international expansion.
Lauxera Capital Partners is an independent, international investment firm focused on growth-stage Healthtech. Its investment profile is specific: companies that have generated significant revenue and reached breakeven or early profitability, where future value is expected to be driven by commercial execution rather than by further financing risk. The sector remit spans medical devices, digital health, pharma services, life science tools, diagnostics, healthtech IT and health data.
Portfolio support is structured around three elements: growth equity investment alongside founders and management teams as they scale; operational and financial input covering business development, talent management and a practical growth toolbox; and assistance with international expansion, including entry into the US market. The firm maintains presence in Paris and San Francisco, and its stated investment thesis is tied to improving patient outcomes, increasing provider productivity and reducing healthcare system costs.
The team combines experienced investors with individuals who have built and led Healthtech companies, and the firm describes its posture as that of an active partner to founders and management teams. Founding year, team size and fund size are not disclosed.